{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:53:12Z","timestamp":1793890392718,"version":"4.8.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["CA160212"],"award-info":[{"award-number":["CA160212"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.eururo.2020.05.039","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T07:36:10Z","timestamp":1592638570000},"page":"209-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Molecular Characterization of Upper Tract Urothelial Carcinoma in the Era of Next-generation Sequencing: A Systematic Review of the Current Literature"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9496-4411","authenticated-orcid":false,"given":"Melanie R.","family":"Hassler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddie","family":"Bray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.F.","family":"Catto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur P.","family":"Grollman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaly","family":"Margulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surena F.","family":"Matin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Sfakianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishoy M.","family":"Faltas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2020.05.039_bib0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","article-title":"European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 update","volume":"73","author":"Roupr\u00eat","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0010","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","article-title":"Urothelial carcinoma of the bladder and the upper tract: disparate twins","volume":"189","author":"Green","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0015","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2008.06.013","article-title":"FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours","volume":"55","author":"van Oers","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0020","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jamaoncol.2015.3209","article-title":"Contemporary occupational carcinogen exposure and bladder cancer: a systematic review and meta-analysis","volume":"1","author":"Cumberbatch","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0025","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","article-title":"Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018","volume":"74","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0030","doi-asserted-by":"crossref","first-page":"12129","DOI":"10.1073\/pnas.0701248104","article-title":"Aristolochic acid and the etiology of endemic (Balkan) nephropathy","volume":"104","author":"Grollman","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.eururo.2020.05.039_bib0035","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41416-018-0356-7","article-title":"Kidney stones and the risk of renal cell carcinoma and upper tract urothelial carcinoma: the Netherlands Cohort Study","volume":"120","author":"van de Pol","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eururo.2020.05.039_bib0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0022-5347(17)39853-1","article-title":"The Lynch syndrome II and urological malignancies","volume":"143","author":"Lynch","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0045","doi-asserted-by":"crossref","unstructured":"Sailer V., Eng K.W., Zhang T., et al. Integrative molecular analysis of patients with advanced and metastatic cancer. JCO Precis Oncol. In press. https:\/\/doi.org\/10.1200\/PO.19.00047.","DOI":"10.1200\/PO.19.00047"},{"key":"10.1016\/j.eururo.2020.05.039_bib0050","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.eururo.2015.07.039","article-title":"Genomic characterization of upper tract urothelial carcinoma","volume":"68","author":"Sfakianos","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0055","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.juro.2016.01.006","article-title":"Genomic biomarkers for the prediction of stage and prognosis of upper tract urothelial carcinoma","volume":"195","author":"Bagrodia","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0060","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/1078-0432.CCR-18-2039","article-title":"Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma","volume":"25","author":"Audenet","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eururo.2020.05.039_bib0065","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.euf.2018.01.005","article-title":"Genomic profile of urothelial carcinoma of the upper tract from ureteroscopic biopsy: feasibility and validation using matched radical nephroureterectomy specimens","volume":"5","author":"Bagrodia","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2020.05.039_bib0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tranon.2017.10.008","article-title":"Molecular characterization of urothelial carcinoma of the bladder and upper urinary tract","volume":"11","author":"Lee","year":"2018","journal-title":"Transl Oncol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0075","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/cncr.31314","article-title":"Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA","volume":"124","author":"Agarwal","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2020.05.039_bib0080","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.eururo.2017.05.048","article-title":"Comprehensive genomic characterization of upper tract urothelial carcinoma","volume":"72","author":"Moss","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0085","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1038\/s41467-019-10873-y","article-title":"Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling","volume":"10","author":"Robinson","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.eururo.2020.05.039_bib0090","doi-asserted-by":"crossref","first-page":"e128728","DOI":"10.1172\/jci.insight.128728","article-title":"Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy","volume":"5","author":"Winters","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.eururo.2020.05.039_bib0095","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/MOU.0000000000000639","article-title":"Lynch syndrome and urologic malignancies: a contemporary review","volume":"29","author":"Lim","year":"2019","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0100","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.2217\/fon-2018-0319","article-title":"Mismatch repair deficiency assessment by immunohistochemistry: for Lynch syndrome screening and beyond","volume":"14","author":"Wong","year":"2018","journal-title":"Future Oncol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0105","doi-asserted-by":"crossref","unstructured":"Donahu T.F., Bagrodia A., Audenet F., et al. Genomic characterization of upper-tract urothelial carcinoma in patients with Lynch syndrome. JCO Precis Oncol. In press. https:\/\/doi.org\/10.1200\/PO.17.00143.","DOI":"10.1200\/PO.17.00143"},{"key":"10.1016\/j.eururo.2020.05.039_bib0110","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/01.MP.0000024263.25043.0C","article-title":"Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis","volume":"15","author":"Blaszyk","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0115","first-page":"6796","article-title":"Frequent microsatellite instability in sporadic tumors of the upper urinary tract","volume":"62","author":"Hartmann","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.eururo.2020.05.039_bib0120","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1038\/sj.onc.1206964","article-title":"Distinct patterns of microsatellite instability are seen in tumours of the urinary tract","volume":"22","author":"Catto","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.eururo.2020.05.039_bib0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2407-5-23","article-title":"Low frequency of defective mismatch repair in a population-based series of upper urothelial carcinoma","volume":"5","author":"Ericson","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.eururo.2020.05.039_bib0130","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/sj.onc.1209229","article-title":"Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tract","volume":"25","author":"Mongiat-Artus","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.eururo.2020.05.039_bib0135","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/PAS.0000000000001141","article-title":"Universal Lynch syndrome screening should be performed in all upper tract urothelial carcinomas","volume":"42","author":"Ju","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0140","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/S0022-5347(06)00256-4","article-title":"Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance","volume":"175","author":"Catto","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0145","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.eururo.2012.07.047","article-title":"Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer","volume":"63","author":"Skeldon","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0150","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/modpathol.2016.171","article-title":"Upper tract urothelial carcinomas: frequency of association with mismatch repair protein loss and lynch syndrome","volume":"30","author":"Harper","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0155","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/iju.13481","article-title":"Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening","volume":"25","author":"Urakami","year":"2018","journal-title":"Int J Urol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0160","doi-asserted-by":"crossref","first-page":"197ra102","DOI":"10.1126\/scitranslmed.3006200","article-title":"Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing","volume":"5","author":"Hoang","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.eururo.2020.05.039_bib0165","doi-asserted-by":"crossref","first-page":"197ra101","DOI":"10.1126\/scitranslmed.3006086","article-title":"Genome-wide mutational signatures of aristolochic acid and its application as a screening tool","volume":"5","author":"Poon","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.eururo.2020.05.039_bib0170","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1158\/1055-9965.EPI-15-0553","article-title":"Low-coverage exome sequencing screen in formalin-fixed paraffin-embedded tumors reveals evidence of exposure to carcinogenic aristolochic acid","volume":"24","author":"Castells","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2020.05.039_bib0175","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1755-8794-3-58","article-title":"Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder","volume":"3","author":"Zhang","year":"2010","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.eururo.2020.05.039_bib0180","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4137\/BMI.S6487","article-title":"FXYD3: a promising biomarker for urothelial carcinoma","volume":"6","author":"Zhang","year":"2011","journal-title":"Biomark Insights"},{"key":"10.1016\/j.eururo.2020.05.039_bib0185","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1186\/1471-2407-14-836","article-title":"Global gene expression profiling identifies ALDH2, CCNE1 and SMAD3 as potential prognostic markers in upper tract urothelial carcinoma","volume":"14","author":"Wu","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.eururo.2020.05.039_bib0190","doi-asserted-by":"crossref","first-page":"e0137141","DOI":"10.1371\/journal.pone.0137141","article-title":"Molecular analysis of upper tract and bladder urothelial carcinoma: results from a microarray comparison","volume":"10","author":"Sanford","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.eururo.2020.05.039_bib0195","doi-asserted-by":"crossref","first-page":"30988","DOI":"10.1038\/srep30988","article-title":"Unique transcriptomic profile of collecting duct carcinomas relative to upper tract urothelial carcinomas and other kidney carcinomas","volume":"6","author":"Malouf","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.eururo.2020.05.039_bib0200","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7150\/ijms.29560","article-title":"Deduction of novel genes potentially involved in upper tract urothelial carcinoma using next-generation sequencing and bioinformatics approaches","volume":"16","author":"Lee","year":"2019","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.eururo.2020.05.039_bib0205","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3390\/ijms20030570","article-title":"Transcriptional analysis of immunohistochemically defined subgroups of non-muscle-invasive papillary high-grade upper tract urothelial carcinoma","volume":"20","author":"Jung","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.eururo.2020.05.039_bib0210","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/1878-0261.12325","article-title":"Molecular subtype classification of urothelial carcinoma in Lynch syndrome","volume":"12","author":"Therkildsen","year":"2018","journal-title":"Mol Oncol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0215","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.eururo.2020.05.039_bib0220","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/bju.12551","article-title":"Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma","volume":"113","author":"Izquierdo","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2020.05.039_bib0225","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.urology.2018.10.004","article-title":"MicroRNA expression profiles in upper tract urothelial carcinoma differentiate tumor grade, stage, and survival: implications for clinical decision-making","volume":"123","author":"Browne","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2020.05.039_bib0230","doi-asserted-by":"crossref","first-page":"16691","DOI":"10.18632\/oncotarget.24672","article-title":"Prognostic value of circulating microRNAs in upper tract urinary carcinoma","volume":"9","author":"Montalbo","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.eururo.2020.05.039_bib0235","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.3892\/mmr.2015.4257","article-title":"Identification of circulating microRNA signatures for upper tract urothelial carcinoma detection","volume":"12","author":"Tao","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.eururo.2020.05.039_bib0240","doi-asserted-by":"crossref","first-page":"e91646","DOI":"10.1371\/journal.pone.0091646","article-title":"New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidney","volume":"9","author":"Zaravinos","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.eururo.2020.05.039_bib0245","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3390\/ijms18081826","article-title":"MiR-30a-5p inhibits epithelial-to-mesenchymal transition and upregulates expression of tight junction protein Claudin-5 in human upper tract urothelial carcinoma cells","volume":"18","author":"Chung","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.eururo.2020.05.039_bib0250","doi-asserted-by":"crossref","first-page":"7450461","DOI":"10.1155\/2016\/7450461","article-title":"MicroRNA profiling in patients with upper tract urothelial carcinoma associated with Balkan endemic nephropathy","volume":"2016","author":"Popovska-Jankovic","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.eururo.2020.05.039_bib0255","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.3892\/mmr.2015.4330","article-title":"Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo","volume":"12","author":"Tao","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.eururo.2020.05.039_bib0260","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature02625","article-title":"Epigenetics in human disease and prospects for epigenetic therapy","volume":"429","author":"Egger","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2020.05.039_bib0265","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1200\/JCO.2005.03.163","article-title":"Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma","volume":"23","author":"Catto","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0270","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1349-7006.2009.01330.x","article-title":"Genome-wide DNA methylation profiles in urothelial carcinomas and urothelia at the precancerous stage","volume":"101","author":"Nishiyama","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.eururo.2020.05.039_bib0275","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1471-2407-14-363","article-title":"A panel of tumor markers, calreticulin, annexin A2, and annexin A3 in upper tract urothelial carcinoma identified by proteomic and immunological analysis","volume":"14","author":"Lu","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.eururo.2020.05.039_bib0280","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1007\/s13277-015-3482-3","article-title":"Serum metabolomic analysis of human upper urinary tract urothelial carcinoma","volume":"36","author":"Li","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0285","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1016\/j.humpath.2013.07.008","article-title":"Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma","volume":"44","author":"Munari","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0290","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.urology.2014.07.050","article-title":"Evaluation of the prognostic significance of altered mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinoma","volume":"84","author":"Bagrodia","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2020.05.039_bib0295","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1464-410X.2008.08292.x","article-title":"Adhesion molecules alpha, beta and gamma-catenin as prognostic factors of tumour progression in upper urinary tract urothelial tumours: the role of AKT-P\/GSK-3beta\/beta-catenin pathway","volume":"104","author":"Izquierdo","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2020.05.039_bib0300","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.prp.2018.02.007","article-title":"Prognostic significance of epithelial-mesenchymal transition phenotypes in upper urinary tract urothelial carcinoma","volume":"214","author":"Cho","year":"2018","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.eururo.2020.05.039_bib0305","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/cncr.32806","article-title":"Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and\/or cell-free DNA results","volume":"126","author":"Pal","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2020.05.039_bib0310","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJMoa1817323","article-title":"Erdafitinib in locally advanced or metastatic urothelial carcinoma","volume":"381","author":"Loriot","year":"2019","journal-title":"N Engl J Med"},{"issue":"suppl_8","key":"10.1016\/j.eururo.2020.05.039_bib0315","first-page":"viii303","volume":"29","author":"Necchi","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2020.05.039_bib0320","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283820304176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283820304176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:07:42Z","timestamp":1759583262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283820304176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0302283820304176"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2020.05.039","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Characterization of Upper Tract Urothelial Carcinoma in the Era of Next-generation Sequencing: A Systematic Review of the Current Literature","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2020.05.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}